Oncoinvent ASA - Cancellation of subsequent repair offering

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA OR JAPAN OR ANY JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL.

Reference is made to the stock exchange announcements published by Oncoinvent ASA (the "Company") on 22 and 23 September 2026 regarding the successful private placement and retail offering (the "Share Issue") of in total 1,650,000 new shares at a subscription price of NOK 90 per share, and the intention to carry out a subsequent repair offering of up to 200,000 new shares (the "Subsequent Offering") at the same subscription price as in the Share Issue depending, inter alia, on the development in the market price of the Company's shares after completion of the Share Issue.

The board of directors of the Company has resolved not to proceed with the Subsequent Offering.

The background for the cancellation is that the Company's shares have traded consistently below the subscription price in the Share Issue, for an extended period of time and at sufficient trading volumes, following completion of the Share Issue. Shareholders wishing to reduce the dilutive effect of the Share Issue have thus had the opportunity to purchase shares in the market at prices below the price which would have been the subscription price in the Subsequent Offering.

This information is subject to disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.

For further information, please contact:

Oystein Soug, Chief Executive Officer
Email: IR@oncoinvent.com